Stocksigma LogoStocksigma Logo

Venus Remedies Secures Five Marketing Authorisations Across Four Key Global Markets

Venus Remedies Limited secured five marketing authorisations across Kazakhstan, Peru, Kuwait, and Argentina on 16th Oct'26, expanding its footprint across

Venus Remedies Secures Five Marketing Authorisations Across Four Key Global Markets

Venus Remedies Ltd 路 Others (Uncategorized) 路 16 Oct 2026, 8:25 pm

Venus Remedies Secures Five Marketing Authorisations Across Four Key Global Markets Venus Remedies Limited secured five marketing authorisations across Kazakhstan, Peru, Kuwait, and Argentina on 16th Oct'26, expanding its footprint across the CIS, Latin America, and Middle East regions. Key approvals include Vancomycin and Fluorouracil in Kazakhstan, Fulvestrant in Peru, Methotrexate in Kuwait, and Meropenem in Argentina. The regulatory clearances strengthen the company鈥檚 critical-care injectables and oncology export portfolio, reinforcing its global growth strategy across high-potential international markets.

Original exchange filing (PDF)

More announcements from Venus Remedies Ltd

All Venus Remedies Ltd announcements